Loading...
XSWX
MOVE
Market cap3.76bUSD
Dec 05, Last price  
151.80CHF
1D
0.13%
1Q
6.60%
IPO
54.35%
Name

Medacta Group SA

Chart & Performance

D1W1MN
XSWX:MOVE chart
P/E
44.30
P/S
5.47
EPS
3.66
Div Yield, %
0.36%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
13.71%
Revenues
591m
+15.62%
219,051,000244,683,000272,610,000310,623,000302,492,000363,126,000437,122,000510,778,000590,580,000
Net income
73m
+53.89%
39,219,00033,496,00045,753,00011,859,00037,091,00051,521,00046,249,00047,362,00072,886,000
CFO
107m
+42.61%
56,313,00051,586,00066,408,00042,635,00059,592,00054,061,00073,510,00075,127,000107,141,000
Dividend
May 10, 20240.55 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
URL
http://www.medacta.com/
IPO date
Apr 04, 2019
Employees
1,537
Domiciled in
CH
Incorporated in
CH

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT